Bill
HB 3236
85(R) - 2017
House Public Health
House Public Health
Drugs
Healthcare
Vote Recommendation
Yes
-
Positive
-
Neutral
-
Neutral
-
Positive
-
Neutral
Author(s)
Kyle Kacal
Bill Caption
Relating to the costs associated
with the provision of certain investigational drugs, biological products, and
devices that are in clinical trials.
Fiscal Notes
From the LBB: No significant fiscal implication to the State is anticipated.
Bill Analysis
Under current law, a manufacturer must provide an investigational drug, biological product, or device to an eligible patient without receiving compensation. This bill would allow a manufacturer to require an eligible patient to pay the costs of or associated with the manufacture of the investigational drugs, biological product, or device.
Vote Recommendation Notes
This bill furthers our free market and limited government principles by allowing a manufacturer to charge a patient for the cost associated with the manufacture of an investigational drug or device being. We support HB 3236.
Read Bill & Check Bill Status